Antin JH - Search Results

1

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.

Antin JH, Chen AR, Couriel DR, Ho VT, Nash RA, Weisdorf D. Antin JH, et al. Biol Blood Marrow Transplant. 2004 Oct;10(10):655-68. doi: 10.1016/j.bbmt.2004.07.007. Biol Blood Marrow Transplant. 2004. PMID: 15389432 Free article. Review. No abstract available.

2

Cytokine dysregulation and acute graft-versus-host disease.

Antin JH, Ferrara JL. Antin JH, et al. Blood. 1992 Dec 15;80(12):2964-8. Blood. 1992. PMID: 1467511 Free article. Review.

3

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, Golan DE, Macklis RM, Tarbell NJ, Lynch E, et al. Antin JH, et al. Blood. 1991 Oct 15;78(8):2139-49. Blood. 1991. PMID: 1717080 Free article.

4

Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.

Pai SY, Fruman DA, Leong T, Neuberg D, Rosano TG, McGarigle C, Antin JH, Bierer BE. Pai SY, et al. Among authors: antin jh. Blood. 1994 Dec 1;84(11):3974-9. Blood. 1994. PMID: 7949153 Free article.

5

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, Parsons SK, Ballen KK, Rimm IJ, Falzarano G, et al. Antin JH, et al. Blood. 1994 Aug 15;84(4):1342-8. Blood. 1994. PMID: 8049450 Free article.

6

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

Fay JW, Wingard JR, Antin JH, Collins RH, Piñeiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ. Fay JW, et al. Among authors: antin jh. Blood. 1996 Apr 15;87(8):3514-9. Blood. 1996. PMID: 8605372 Free article. Clinical Trial.

7

Treatment of chronic graft-versus-host disease with clofazimine.

Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH. Lee SJ, et al. Among authors: antin jh. Blood. 1997 Apr 1;89(7):2298-302. Blood. 1997. PMID: 9116272 Free article. Clinical Trial.

8

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.

Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH. Ballen KK, et al. Among authors: antin jh. Bone Marrow Transplant. 1997 Nov;20(9):737-43. doi: 10.1038/sj.bmt.1700971. Bone Marrow Transplant. 1997. PMID: 9384475 Clinical Trial.

9

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR. Ratanatharathorn V, et al. Among authors: antin jh. Blood. 1998 Oct 1;92(7):2303-14. Blood. 1998. PMID: 9746768 Free article. Clinical Trial.

10

A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.

Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, Antin JH, LeBherz D, Awwad M, Hope J, McClain JB. Przepiorka D, et al. Among authors: antin jh. Blood. 1998 Dec 1;92(11):4066-71. Blood. 1998. PMID: 9834211 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

499 results

Search Page